Treating depression during COVID-19: Considerations for psychological and psychiatric treatment

Presented by Rachel Leonard, PhD, LP, and Christopher Lowden, MD

Review behavioral activation theory and pharmacotherapy for depression, and gain an understanding of the benefits of a combined approach, in part one of this webinar series. Time will also be spent identifying necessary modifications for pharmacotherapy during COVID-19 and adaptations for behavioral activation, which are necessary when treatment is provided via telehealth.